1. Home
  2. TNGX vs BRT Comparison

TNGX vs BRT Comparison

Compare TNGX & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • BRT
  • Stock Information
  • Founded
  • TNGX 2014
  • BRT 1972
  • Country
  • TNGX United States
  • BRT United States
  • Employees
  • TNGX N/A
  • BRT N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • BRT Real Estate Investment Trusts
  • Sector
  • TNGX Health Care
  • BRT Real Estate
  • Exchange
  • TNGX Nasdaq
  • BRT Nasdaq
  • Market Cap
  • TNGX 317.4M
  • BRT 331.7M
  • IPO Year
  • TNGX N/A
  • BRT N/A
  • Fundamental
  • Price
  • TNGX $1.80
  • BRT $17.88
  • Analyst Decision
  • TNGX Strong Buy
  • BRT Strong Buy
  • Analyst Count
  • TNGX 7
  • BRT 3
  • Target Price
  • TNGX $12.33
  • BRT $22.17
  • AVG Volume (30 Days)
  • TNGX 791.2K
  • BRT 19.7K
  • Earning Date
  • TNGX 05-07-2025
  • BRT 05-07-2025
  • Dividend Yield
  • TNGX N/A
  • BRT 5.73%
  • EPS Growth
  • TNGX N/A
  • BRT N/A
  • EPS
  • TNGX N/A
  • BRT N/A
  • Revenue
  • TNGX $42,069,000.00
  • BRT $97,274,000.00
  • Revenue This Year
  • TNGX N/A
  • BRT N/A
  • Revenue Next Year
  • TNGX N/A
  • BRT $5.39
  • P/E Ratio
  • TNGX N/A
  • BRT N/A
  • Revenue Growth
  • TNGX 15.17
  • BRT 1.65
  • 52 Week Low
  • TNGX $1.72
  • BRT $15.81
  • 52 Week High
  • TNGX $12.02
  • BRT $20.22
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 34.74
  • BRT 47.40
  • Support Level
  • TNGX $1.80
  • BRT $17.36
  • Resistance Level
  • TNGX $2.04
  • BRT $19.01
  • Average True Range (ATR)
  • TNGX 0.20
  • BRT 0.61
  • MACD
  • TNGX 0.02
  • BRT -0.02
  • Stochastic Oscillator
  • TNGX 19.40
  • BRT 18.71

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About BRT BRT Apartments Corp. (MD)

BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.

Share on Social Networks: